Skip to main content
. 2011 May 31;16(6):859–867. doi: 10.1634/theoncologist.2011-0064

Table 3.

Multivariate analysis for overall survival (24-week landmark, N = 1,116)

graphic file with name onc00611-0839-t03.jpg

aResponse of CR/PR is the reference group for 24-week response comparisons.

bArm A (IFL) is reference group for treatment comparisons.

cReference is 0–1.

Abbreviations: CI, confidence interval; CR, complete response; FOLFOX, oxaliplatin and infused fluorouracil plus leucovorin; HR, hazard ratio; IFL, irinotecan and bolus fluorouracil plus leucovorin; IROX, irinotecan and oxaliplatin; PR, partial response; PS, performance status; TM, tumor measurement.